Schistosoma mansoni antigens as Modulators of the allergic inflammatory response in asthma

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 1, 2012, Pages 24-32

  Cardoso, Luciano S ^a,b   Oliveira, Sergio C ^c,d   Araujo, Maria I ^a,d,e  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSIDADE DO ESTADO DA BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais INCT DT CNPq MCT   (Brazil)

^e ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Allergy; Asthma; Atopy; Helminths; Schistosomiasis

Indexed keywords

ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MYELOID DIFFERENTIATION FACTOR 88; SCHISTOSOMA MANSONI ANTIGEN; SCHISTOSOMA VACCINE; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HELIGMOSOMOIDES POLYGYRUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFECTION RESISTANCE; INFLAMMATION; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; MAST CELL; MEMORY T LYMPHOCYTE; NONHUMAN; PRICK TEST; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; SKIN TEST; TH1 CELL; TH2 CELL;

EID: 84857131929     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012799278929     Document Type: Review

References (108)

1. Sears, M.R. (1997) Descriptive epidemiology of asthma. Lancet, 350 Suppl 2, SII1-SII4.
2. Yazdanbakhsh, M.; Kremsner, P.G. and van Ree, R. (2002) Allergy, parasites, and the hygiene hypothesis. Science, 296, 490-494.
3. Smits, H.H. and Yazdanbakhsh, M. (2007) Chronic helminth infections modulate allergen-specific immune responses: Protection. against development of allergic disorders? Ann. Med., 39, 428-439.
4. Romagnani S. (1997) Atopic allergy and other hypersensitivities interactions between genetic susceptibility, innocuous and/or microbial antigens and the immune system. Curr. Opin. Immunol., 9, 773-775.
5. Foster, P.S.; Hogan, S.P.; Ramsay, A.J.; Matthaei, K.I. and Young, I.G. (1996). Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med., 183, 195-201.
6. Soroosh, P. and Doherty, T.A. (2009) Th9 and allergic disease. Immunology, 127, 450-458.
7. Else, K.J.; Finkelman, F.D.; Maliszewski, C.R. and Grencis R.K. (1994) Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med., 179, 347-351.
8. Yazdanbakhsh, M.; van den Biggelaar, A. and Maizels R.M. (2001) Th2 responses without atopy: Immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol., 22, 372-377.
9. + T cells in atopic asthma. Am. J. Respir. Crit. Care Med., 171, 224-230.
10. Smart, J.M. and Kemp, A.S. (2002) Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin. Exp. Allergy, 32, 796-802.
11. Ying, S.; O'Connor, B.; Ratoff, J.; Meng, Q.; Fang, C.; Cousins, D.; Zhang, G.; Gu, S.; Gao, Z.; Shamji, B.; Edwards, M.J.; Lee, T.H. and Corrigan, C.J. (2008) Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J. Immunol., 181, 2790-2798.
12. Ying, S.; O'Connor, B.; Ratoff, J.; Meng, Q.; Mallett, K.; Cousins, D.; Robinson, D.; Zhang, G.; Zhao, J.; Lee, T.H. and Corrigan, C. (2005) Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol., 174, 8183-8190.
13. Zhou, B.; Comeau, M.R.; De Smedt, T.; Liggitt, H.D.; Dahl, M.E.; Lewis, D.B.; Gyarmati, D.; Aye, T.; Campbell, D.J. and Ziegler, S.F. (2005) Thymic stromal lymphopoietin as a key initiator of. allergic airway inflammation in mice. Nat. Immunol., 6, 1047-1053.
14. Al-Shami, A.; Spolski, R.; Kelly, J.; Keane-Myers, A. and Leonard, W.J. (2005) A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med., 202, 829-839.
15. Wang, Y.H.; Angkasekwinai, P.; Lu, N.; Voo, K.S.; Arima, K.; Hanabuchi, S.; Hippe, A.; Corrigan, C.J.; Dong, C.; Homey, B.; Yao, Z.; Ying, S.; Huston, D.P. and Liu, Y.J. (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med., 204, 1837-1847.
16. Angkasekwinai, P.; Park, H.; Wang, Y.H.; Chang, S.H.; Corry, D.B.; Liu, Y.J.; Zhu, Z. and Dong, C. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med., 204, 1509-1517.
17. Sharkhuu, T.; Matthaei, K.I.; Forbes, E.; Mahalingam, S.; Hogan, S.P.; Hansbro, P.M. and Foster, P.S. (2006) Mechanism of Interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin. Exp. Allergy, 36, 1575-1583.
18. Ballantyne, S.J.; Barlow, J.L.; Jolin, H.E.; Nath, P.; Williams, A.S.; Chung, K.F.; Sturton, G.; Wong, S.H. and McKenzie, A.N. (2007) Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol., 20, 1324-1331.
19. Tamachi, T.; Maezawa, Y.; Ikeda, K.; Iwamoto, I. and Nakajima, H. (2006) Interleukin 25 in allergic airway inflammation. Int. Arch. Allergy Immunol., 140, 59-62.
20. Cheung, P.F.; Wong, C.K.; Ip, W.K. and Lam, C.W. (2006) IL-25 regulates the expression of adhesion molecules on eosinophils: Mechanism of eosinophilia in allergic inflammation. Allergy, 61, 878-885.
21. Simpson, J.L.; Scott, R.; Boyle, M.J. and Gibson, P.G. (2006) Inflammatory subtypes in asthma: Assessment and identification using induced sputum. Respirology, 11, 54-61.
22. Oboki, K.; Ohno, T.; Saito, H. and Nakae, S. (2008) Th17 and allergy. Allergol. Int., 57, 121-134.
23. Humbert, M.; Menz, G.; Ying, S.; Corrigan, C.J.; Robinson, D.S.; Durham, S.R. and Kay, A.B. (1999) The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences. Immunol. Today, 20, 528-533.
24. Walker C. (1993) The immunology of extrinsic and intrinsic asthma. Agents Actions Suppl., 43, 97-106.
25. Schmitz, J.; Owyang, A.; Oldham, E.; Song, Y.; Murphy, E.; McClanahan, T.K.; Zurawski, G.; Moshrefi, M.; Qin, J.; Li, X.; Gorman, D.M.; Bazan, J.F. and Kastelein, R.A. (2005) IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-relatedprotein ST2 and induces T helper type 2-associated cytokines. Immunity, 23, 479-490.
26. Baekkevold, E.S.; Roussigne, M.; Yamanaka, T.; Johansen, F.E.; Jahnsen, F.L.; Amalric, F.; Brandtzaeg, P.; Erard, M.; Haraldsen, G. and Girard, J.P. (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol., 163, 69-79.
27. Wood, I.S.; Wang, B. and Trayhurn, P. (2009) IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun., 384, 105-109.
28. Moussion, C.; Ortega, N. and Girard, J.P. (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel 'alarmin'? PLoS One, 3, e3331.
29. Kondo, Y.; Yoshimoto, T.; Yasuda, K.; Futatsugi-Yumikura, S.; Morimoto, M.; Hayashi, N.; Hoshino, T.; Fujimoto, J. and. Nakanishi, K. (2008) Administration of IL-33 induces airway. hyperresponsiveness and goblet cell hyperplasia in the lungs in the. absence of adaptive immune system. Int. Immunol., 20, 791-800.
30. Carriere, V.; Roussel, L.; Ortega, N.; Lacorre, D.A; Americh, L.; Aguilar, L.; Bouche, G. and Girard, J.P. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA, 104, 282-287.
31. Suzukawa, M.; Koketsu, R.; Iikura, M.; Nakae, S.; Matsumoto, K.; Nagase, H.; Saito, H.; Matsushima, K.; Ohta, K.; Yamamoto, K. and Yamaguchi, M. (2008) Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest., 88, 1245-1253.
32. Iikura, M.; Suto, H.; Kajiwara, N.; Oboki, K.; Ohno, T.; Okayama, Y.; Saito, H.; Galli, S.J. and Nakae, S. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest., 87, 971-978.
33. Ho, L.H.; Ohno, T.; Oboki, K.; Kajiwara, N.; Suto, H.; Iikura, M.; Okayama, Y.; Akira, S.; Saito, H.; Galli, S.J. and Nakae, S. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc epsilon signals. J. Leukoc. Biol., 82, 1481-1490.
34. Allakhverdi, Z.; Smith, D.E.; Comeau, M.R. and Delespesse, G. (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol., 179, 2051-2054.
35. Komai-Koma, M.; Xu, D.; Li, Y.; McKenzie, A.N.; McInnes, I.B. and Liew, F.Y. (2007) IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol., 37, 2779-2786.
36. Humphreys, N.E.; Xu, D.; Hepworth, M.R.; Liew, F.Y. and Grencis, R.K. (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol., 180, 2443-2449.
37. Smith, D.E. (2009) IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin. Exp. Allergy, 40, 200-208.
38. Fiorentino, D.F.; Bond, M.W. and Mosmann, T.R. (1989) Two types of mouse t helper cell. Iv. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170, 2081-2095.
39. Akdis, C.A. and Blaser, K. (2001) Mechanisms of Interleukin-10-mediated immune suppression. Immunology, 103, 131-136.
40. Del Prete, G.; De Carli, M.; Almerigogna, F.; Giudizi, M.G.; Biagiotti, R. and Romagnani, S. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 150, 353-360.
41. +T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol., 147, 2713-2716.
42. Royer, B.; Varadaradjalou, S.; Saas, P.; Guillosson, J.J.; Kantelip, J.P. and Arock, M. (2001) Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy, 31, 694-704.
43. Cooke, A.; Tonks, P.; Jones, F.M.; O'Shea, H.; Hutchings, P.; Fulford, A.J. and Dunne. D.W. (1999) Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol., 21, 169-176.
44. rd and Cooke A. (2002) Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur. J. Immunol., 32, 1021-1028.
45. Zaccone, P.; Burton, O.; Miller, N.; Jones, F.M.; Dunne, D.W. and Cooke, A. (2009) Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in nod mice. Eur. J. Immunol., 39, 1098-1107.
46. + regulatory T cells. Immunology, 127, 512-522.
47. Liu, Q.; Sundar, K.; Mishra, P.K.; Mousavi, G.; Liu, Z.; Gaydo, A.; Alem, F.; Lagunoff, D.; Bleich, D. and Gause, W.C. (2009) Helminth infection can reduce insulitis and type 1 diabetes through CD25-and IL-10-independent mechanisms. Infect. Immun., 77, 5347-5358.
48. La Flamme, A.C.; Ruddenklau, K. and Backstrom, B.T. (2003) Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun., 71, 4996-5004.
49. Sewell, D.; Qing, Z.; Reinke, E.; Elliot, D.; Weinstock, J.; Sandor, M. and Fabry, Z. (2003) Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol., 15, 59-69.
50. Panitch, H.S. (1992) Interferons in multiple sclerosis. A review of the evidence. Drugs, 44, 946-962.
51. Panitch, H.S.; Hirsch, R.L.; Haley, A.S. and Johnson, K.P. (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet, 1, 893-895.
52. Zheng, X.; Hu, X.; Zhou, G.; Lu, Z.; Qiu, W.; Bao, J. and Dai, Y. (2008) Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J. Neuroimmunol., 194, 107-114.
53. McInnes, I.B.; Leung, B.P.; Harnett, M.; Gracie, J.A.; Liew, F.Y. and Harnett, W. (2003) A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein es-62. J. Immunol., 171, 2127-2133.
54. Rocha, F.A.; Leite, A.K.; Pompeu, M.M.; Cunha, T.M.; Verri, W.A. Jr.; Soares, F.M.; Castro, R.R. and Cunha, F.Q. (2008) Protective effect of an extract from Ascaris suum in experimental arthritis models. Infect. Immun., 76, 2736-2745.
55. Osada, Y.; Shimizu, S.; Kumagai, T.; Yamada, S. and Kanazawa, T. (2009) Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int. J. Parasitol., 39, 457-464.
56. Neurath, M.F.; Fuss, I.; Kelsall, B.L.; Stuber, E. and Strober, W. (1995) Antibodies to Interleukin-12 abrogate established experimental colitis in mice. J. Exp. Med., 182, 1281-1290.
57. Moreels, T.G.; Nieuwendijk, R.J.; De Man, J.G.; De Winter, B.Y.; Herman, A.G.; Van Marck, E.A. and Pelckmans, P.A. (2004) Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut, 53, 99-107.
58. Elliott, D.E.; Li, J.; Blum, A.; Metwali, A.; Qadir, K.; Urban, J.F. Jr. and Weinstock, J.V. (2003) Exposure to Schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 284, G385-391.
59. Summers, R.W.; Elliott, D.E.; Qadir, K.; Urban, J.F. Jr.; Thompson, R. and Weinstock, J.V. (2003) Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol., 98, 2034-2041.
60. Barnes KC. (2006) Genetic epidemiology of health disparities in allergy and clinical immunology. J. Allergy Clin. Immunol., 117, 243-254; quiz 255-246.
61. Araujo, M.I.; Lopes, A.A.; Medeiros, M.; Cruz, A.A.; Sousa-Atta, L.; Sole, D. and Carvalho, E.M. (2000) Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int. Arch. Allergy Immunol., 123, 145-148.
62. van den Biggelaar, A.H.; Lopuhaa, C.; van Ree, R.; van der Zee, J.S.; Jans, J.; Hoek, A.; Migombet, B.; Borrmann, S.; Luckner, D.; Kremsner, P.G. and Yazdanbakhsh, M. (2001) The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int. Arch. Allergy Immunol., 126, 231-238.
63. Duffy, D.L. (2001) Applying statistical approaches in the dissection of genes versus environment for asthma and allergic disease. Curr. Opin. Allergy Clin. Immunol., 1, 431-434.
64. Abel, L.; Demenais, F.; Prata, A.; Souza, A.E. and Dessein, A. (1991) Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet., 48, 959-970.
65. Bethony, J.; Williams, J.T.; Blangero, J.; Kloos, H.; Gazzinelli, A.; Soares-Filho, B.; Coelho, L.; Alves-Fraga, L.; Williams-Blangero, S.; Loverde, P.T. and Correa-Oliveira, R. (2002) Additive host genetic factors influence fecal egg excretion rates during Schistosoma mansoni infection in a rural area in Brazil. Am. J. Trop. Med. Hyg., 67, 336-343.
66. Bethony, J.; Williams, J.T.; Kloos, H.; Blangero, J.; Alves-Fraga, L.; Buck, G.; Michalek, A.; Williams-Blangero, S.; Loverde, P.T.; Correa-Oliveira, R. and Gazzinelli, A. (2001) Exposure to Schistosoma mansoni infection in a rural area in Brazil. II: Household risk factors. Trop. Med. Int. Health, 6, 136-145.
67. Grant, A.V.; Araujo, M.I.; Ponte, E.V.; Oliveira, R.R.; Cruz, A.A.; Barnes, K.C. and Beaty, T.H. (2008) High heritability but uncertain mode of inheritance for total serum IgE level and Schistosoma mansoni infection intensity in a Schistosomiasis-endemic brazilian population. J. Infect. Dis., 198, 1227-1236.
68. Marsh, D.G.; Neely, J.D.; Breazeale, D.R.; Ghosh, B.; Freidhoff, L.R.; Ehrlich-Kautzky, E.; Schou, C.; Krishnaswamy, G.; Beaty, T.H. (1994) Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin e concentrations. Science, 264, 1152-1156.
69. Meyers, D.A.; Postma, D.S.; Panhuysen, C.I.; Xu, J.; Amelung, P.J.; Levitt, R.C. and Bleecker, E.R. (1994) Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics, 23, 464-470.
70. Wills-Karp, M. and Ewart, S.L. (2004) Time to draw breath: Asthma-susceptibility genes are identified. Nat. Rev. Genet., 5, 376-387.
71. Marquet, S.; Abel, L.; Hillaire, D.; Dessein, H.; Kalil, J.; Feingold, J.; Weissenbach, J. and Dessein, A.J. (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet., 14, 181-184.
72. Marquet, S.; Abel, L.; Hillaire, D.; Dessein, A. (1999) Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur. J. Hum. Genet., 7, 88-97.
73. Caldas, I.R.; Campi-Azevedo, A.C.; Oliveira, L.F.; Silveira, A.M.; Oliveira, R.C. and Gazzinelli, G. (2008) Human Schistosomiasis mansoni: Immune responses during acute and chronic phases of the infection. Acta Trop., 108, 109-117.
74. Pearce, E.J. and MacDonald, A.S. (2002) The immunobiology of schistosomiasis. Nat. Rev. Immunol., 2, 499-511.
75. Belkaid, Y.; Blank, R.B. and Suffia, I. (2006) Natural regulatory T cells and parasites: A common quest for host homeostasis. Immunol. Rev., 212, 287-300.
76. Robinson, D.S.; Larche, M. and Durham, S.R. (2004) Tregs and allergic disease. J. Clin. Invest., 114, 1389-1397.
77. van den Biggelaar, A.H.; van Ree, R.; Rodrigues, L.C.; Lell, B.; Deelder, A.M.; Kremsner, P.G. and Yazdanbakhsh, M. (2000) Decreased atopy in children infected with Schistosoma haematobium: A role for parasite-induced interleukin-10. Lancet, 356, 1723-1727.
78. Araujo, M.I.; Hoppe, B.; Medeiros, M. Jr.; Alcantara, L.; Almeida, M.C.; Schriefer, A.; Oliveira, R.R.; Kruschewsky, R.; Figueiredo, J.P.; Cruz, A.A. and Carvalho, E.M. (2004) Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J. Infect. Dis., 190, 1797-1803.
79. Capron, A.; Dombrowicz, D. and Capron, M. (2004) Helminth infections and allergic diseases: From the Th2 paradigm to regulatory networks. Clin. Rev. Allergy Immunol., 26, 25-34.
80. van den Biggelaar, A.H.; Rodrigues, L.C.; van Ree, R.; van der Zee, J.S.; Hoeksma-Kruize, Y.C.; Souverijn, J.H.; Missinou, M.A.;. Borrmann, S.; Kremsner, P.G. and Yazdanbakhsh, M. (2004). Long-term treatment of intestinal helminths increases mite skin-test. reactivity in gabonese schoolchildren. J. Infect. Dis., 189, 892-900.
81. Medeiros, M. Jr.; Figueiredo, J.P.; Almeida, M.C.; Matos, M.A.; Araujo, M.I.; Cruz, A.A.; Atta, A.M.; Rego, M.A.; de Jesus, A.R.; Taketomi, E.A. and Carvalho, E.M. (2003) Schistosoma mansoni infection is associated with a reduced course of asthma. J. Allergy Clin. Immunol., 111, 947-951.
82. Grant, A.V.; Araujo, M.I.; Ponte, E.V.; Oliveira, R.R.; Cruz, A.A.; Barnes, K.C. and Beaty, T.H. (2011) Polymorphisms in IL-10 are associated with total immunoglobulin E levels and Schistosoma mansoni infection intensity in a brazilian population. Genes Immun., 12, 46-50.
83. Hagel, I.; Lynch, N.R.; Perez, M.; Di Prisco, M.C.; Lopez, R. and Rojas, E. (1993) Modulation of the allergic reactivity of slum. children by helminthic infection. Parasite Immunol., 15, 311-315.
84. Lynch, N.R.; Hagel, I.; Perez, M.; Di Prisco, M.C.; Lopez, R. and Alvarez, N. (1993) Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allergy Clin. Immunol., 92, 404-411.
85. Cooper, P.J.; Chico, M.E.; Rodrigues, L.C.; Ordonez, M.; Strachan, D.; Griffin, G.E. and Nutman, T.B. (2003) Reduced risk of atopy. among school-age children infected with geohelminth parasites in a. rural area of the tropics. J. Allergy Clin. Immunol., 111, 995-1000.
86. Hussain, R.; Poindexter, R.W. and Ottesen, E.A. (1992) Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol., 148, 2731-2737.
87. Araujo, M.I.; Hoppe, B.S.; Medeiros, M. Jr. and Carvalho, E.M. (2004) Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem. Inst. Oswaldo Cruz, 99, 27-32.
88. Tsuyuki, S.; Tsuyuki, J.; Einsle, K.; Kopf, M. and Coyle, A.J. (1997) Costimulation through B7-2 (CD86) is required for the. induction of a lung mucosal T helper cell 2 (Th2) immune response. and altered airway responsiveness. J. Exp. Med., 185, 1671-1679.
89. Mandelbrot, D.A.; McAdam, A.J. and Sharpe, A.H. (1999) B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med., 189, 435-440.
90. Munthe-Kaas, M.C.; Carlsen, K.H.; Helms, P.J.; Gerritsen, J.; Whyte, M.; Feijen, M.; Skinningsrud, B.; Main, M.; Kwong, G.N.; Lie, B.A.; Lodrup Carlsen, K.C. and Undlien, D.E. (2004) CTLA-4 polymorphisms in allergy and asthma and the Th1/ Th2 paradigm. J. Allergy Clin. Immunol., 114, 280-287.
91. Heward, J.M.; Allahabadia, A.; Armitage, M.; Hattersley, A.; Dodson, P.M.; Macleod, K.; Carr-Smith, J.; Daykin, J.; Daly, A.; Sheppard, M.C.; Holder, R.L.; Barnett, A.H.; Franklyn, J.A. and Gough, S.C. (1999) The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab., 84, 2398-2401.
92. Nistico, L.; Buzzetti, R.; Pritchard, L.E.; Van der Auwera, B.; Giovannini, C.; Bosi, E.; Larrad, M.T.; Rios, M.S.; Chow, C.C.; Cockram, C.S.; Jacobs, K.; Mijovic, C.; Bain, S.C.; Barnett, A.H.; Vandewalle, C.L.; Schuit, F.; Gorus, F.K.; Tosi, R.; Pozzilli, P. and Todd, J.A. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry. Hum. Mol. Genet., 5, 1075-1080.
93. Hudson, L.L.; Rocca, K.; Song, Y.W. and Pandey, J.P. (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: A highly significant association with a determinant in the promoter region. Hum. Genet., 111, 452-455.
94. Oliveira, R.R.; Gollob, K.J.; Figueiredo, J.P.; Alcantara, L.M.; Cardoso, L.S.; Aquino, C.S.; Campos, R.A.; Almeida, M.C.; Carvalho, E.M. and Araujo, M.I. (2009) Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect., 11, 223-229.
95. Amu, S.; Saunders, S.P.; Kronenberg, M.; Mangan, N.E.; Atzberger, A. and Fallon, P.G. (2010) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol., 125, 1114-1124 e1118.
96. +T cells independent of Interleukin-10. Infect. Immun., 77, 98-107.
97. Jeffs, S.A.; Hagan, P.; Allen, R.; Correa-Oliveira, R.; Smithers, S.R. and Simpson, A.J. (1991) Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol. Biochem. Parasitol., 46, 159-167.
98. Cardoso, F.C.; Pacifico, R.N.; Mortara, R.A. and Oliveira, S.C. (2006) Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin. Exp. Immunol., 144, 382-391.
99. Hirsch, C. and Goes, A.M. (1996) Characterization of fractionated Schistosoma mansoni soluble adult worm antigens that elicit human cell proliferation and granuloma formation in vitro. Parasitology, 112(Pt 6), 529-535.
100. Oliveira, D.M.; Gustavson, S.; Silva-Teixeira, D.N.; and Goes,. A.M. (1999) Nitric oxide and IL-10 production induced by PIII-a fraction of Schistosoma mansoni adult worm antigenic preparation-associated with downregulation of in vitro granuloma formation. Hum Immunol., 60, 305-311.
101. Zouain, C.S.; Gustavson, S.; Silva-Teixeira, D.N.; Contigli, C.;. Rodrigues, V. Jr., Leite, M.F. and Goes, A.M. (2002) Human immune response in schistosomiasis: The role of P24 in the modulation of cellular reactivity to Schistosoma mansoni antigens. Hum Immunol., 63, 647-656.
102. Zouain, C.S.; Gustavson, S.; Oliveira, S.C.; Azevedo, V.; Alves,. J.B. and Goes, A.M. (2000) The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice. Vaccine, 19, 1218-1224.
103. Cardoso, L.S.; Oliveira, S.C.; Pacifico, L.G.; Goes, A.M.; Oliveira, R.R.; Fonseca, C.T.; Carvalho, E.M. and Araujo, M.I. (2006) Schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals. Mem. Inst. Oswaldo Cruz, 101, Suppl 1, 339-343.
104. Cardoso. L.S.; Oliveira, S.C.; Goes, A.M.; Oliveira, R.R.; Pacifico. L.G.; Marinho, F.V.; Fonseca, C.T.; Cardoso, F.C.; Carvalho, E.M. and Araujo, M.I. (2010) Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin. Exp. Immunol., 160, 266-274.
105. Chung, K.F. (2004) Anti-IgE monoclonal antibody, omalizumab: A new treatment for allergic asthma. Expert. Opin. Pharmacother., 5, 439-446.
106. Noga, O.; Hanf, G. and Kunkel, G. (2003) Immunological and. clinical changes in allergic asthmatics following treatment with omalizumab. Int. Arch Allergy Immunol., 131, 46-52.
107. Akdis, C.A. and Blaser, K. (2001) Immunologic mechanisms of allergen-specific immunotherapy. Adv. Exp. Med. Biol., 495, 247-259.
108. Akdis, C.A. and Blaser, K. (2001) Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect., 3, 891-898.